Structure-based Virtual Screening for Identification of Potential CDC20 Inhibitors and Their Therapeutic Evaluation in Breast Cancer

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2023 May 1

PMID 37124982

Authors

Amiya Das

Hitesh Kumar Sharma

Viney Lather

Deepti Pandita

Pallavi Agarwal

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-023-03554-7.

References

Yao H, He G, Yan S, Chen C, Song L, Rosol T . Triple-negative breast cancer: is there a treatment on the horizon?. Oncotarget. 2016; 8(1):1913-1924. PMC: 5352107. DOI: 10.18632/oncotarget.12284. View

Liu N, Wang X, Zhu Z, Li D, Lv X, Chen Y . Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology. Aging (Albany NY). 2021; 13(20):23702-23725. PMC: 8580355. DOI: 10.18632/aging.203642. View

Karra H, Repo H, Ahonen I, Loyttyniemi E, Pitkanen R, Lintunen M . Cdc20 and securin overexpression predict short-term breast cancer survival. Br J Cancer. 2014; 110(12):2905-13. PMC: 4056061. DOI: 10.1038/bjc.2014.252. View

Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View

Bibi Z . Role of cytochrome P450 in drug interactions. Nutr Metab (Lond). 2008; 5:27. PMC: 2584094. DOI: 10.1186/1743-7075-5-27. View

Wang K, Zhu X, Zhang K, Zhu L, Zhou F . Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells. J Biochem Mol Toxicol. 2014; 28(9):387-93. DOI: 10.1002/jbt.21575. View

Daly A . Pharmacogenetics of the cytochromes P450. Curr Top Med Chem. 2004; 4(16):1733-44. DOI: 10.2174/1568026043387070. View

Chamaraux-Tran T, Mathelin C, Aprahamian M, Joshi G, Tomasetto C, Diemunsch P . Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An and Experimental Trial. Anticancer Res. 2017; 38(1):95-105. DOI: 10.21873/anticanres.12196. View

Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W . Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther. 2015; 151:141-51. PMC: 4457591. DOI: 10.1016/j.pharmthera.2015.04.002. View

10.

Song C, Lowe V, Lee S . Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC). Breast Cancer. 2021; 28(5):1073-1086. DOI: 10.1007/s12282-021-01242-z. View

11.

Nigg E . Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001; 2(1):21-32. DOI: 10.1038/35048096. View

12.

Wavelet-Vermuse C, Odnokoz O, Xue Y, Lu X, Cristofanilli M, Wan Y . CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response. Cancers (Basel). 2022; 14(15). PMC: 9367339. DOI: 10.3390/cancers14153732. View

13.

de Lima Menezes G, da Silva R . Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1). J Biomol Struct Dyn. 2020; 39(15):5657-5667. PMC: 7443570. DOI: 10.1080/07391102.2020.1792992. View

14.

Zeng X, Sigoillot F, Gaur S, Choi S, Pfaff K, Oh D . Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell. 2010; 18(4):382-95. PMC: 2957475. DOI: 10.1016/j.ccr.2010.08.010. View

15.

Jezequel P, Gouraud W, Ben Azzouz F, Guerin-Charbonnel C, Juin P, Lasla H . bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database (Oxford). 2021; 2021. PMC: 7904047. DOI: 10.1093/database/baab007. View

16.

Jarada T, Rokne J, Alhajj R . A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. J Cheminform. 2021; 12(1):46. PMC: 7374666. DOI: 10.1186/s13321-020-00450-7. View

17.

Han B, Jung K, Lee J, Yoon Y, Ko S, Park M . Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer. Am J Cancer Res. 2022; 12(7):3083-3098. PMC: 9360229. View

18.

Sackton K, Dimova N, Zeng X, Tian W, Zhang M, Sackton T . Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C. Nature. 2014; 514(7524):646-9. PMC: 4214887. DOI: 10.1038/nature13660. View

19.

Bhardwaj V, Singh R, Sharma J, Das P, Purohit R . Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase. Comput Methods Programs Biomed. 2020; 194:105494. DOI: 10.1016/j.cmpb.2020.105494. View

20.

Haupt L, Kazmi F, Ogilvie B, Buckley D, Smith B, Leatherman S . The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments. Drug Metab Dispos. 2015; 43(11):1744-50. DOI: 10.1124/dmd.115.066597. View